At Veranova, we specialize in the development, manufacturing, and analytical testing of novel modalities and complex small molecules. As a leading drug substance CDMO with over 50 years of experience, Veranova provides integrated solutions to accelerate your program and reduce risk.

  • ADC linkers and payloads: 20 years of experience with complex synthesis
  • Bioconjugation: Expanding capabilities for conjugate development
  • Highly potent APIs and payloads: Specialized experience and infrastructure
  • TIDES: 25+ years of experience in phosphoramidites
  • Other specialty modalities: PEGs, lipids, and PROTACs delivered with expertise
  • Complex small-molecule synthesis: Crystallization, solid-form, and particle engineering

To discover how you can get the expert support you need for your complex molecules, contact us today.

Scientist wearing PPE in the lab
Get in Touch Our CDMO Approach
Plastic vials

Enabling Formulation: A Data Driven Approach to Accelerating Drug Development

Read our white paper to learn how an integrated approach, from pre-candidate selection to advanced development strategies, enables the identification of optimal drug formulations.

The Role of CDMOs in Driving Innovation Through Phase-Appropriate Technology Transfers

Read our white paper to discover more about the role of CDMOs in drug development.

Dan Coughlin presents at SCALE

Managing Challenges in Controlled Substance Manufacturing

Watch a presentation exploring the evolving landscape of controlled substances – how they are regulated, manufactured, and responsibly used in modern medicine.

Veranova is your next great decision

Discover new ways to advance your science with Veranova.

Contact us